How long do benzodiazepines remain detectable on Urine Drug Screens (UDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Benzodiazepines can be detected in urine drug screens (UDS) for up to 48 hours after ingestion, as seen with flunitrazepam 1. However, the detection time may vary depending on the specific benzodiazepine, dosage, and individual factors. Some benzodiazepines, like flunitrazepam, can be detected in urine for up to 48 hours 1, while others may have shorter or longer detection times. It's essential to note that standard immunoassay UDS tests may not detect all benzodiazepines, and confirmatory testing may be necessary for definitive results 1. Factors such as individual metabolism, age, body mass, and kidney/liver function can also influence detection times. In general, benzodiazepines can be detected in urine for several days after last use, but the exact timeframe can vary significantly. For example, some studies suggest that benzodiazepines can be detected for 3-7 days after last use, while others may be detectable for up to 10-14 days or even longer. It's crucial to consider these factors when interpreting UDS results and to consult with laboratory personnel if necessary 1. Key points to consider include:

  • Detection times vary depending on the specific benzodiazepine and individual factors
  • Standard immunoassay UDS tests may not detect all benzodiazepines
  • Confirmatory testing may be necessary for definitive results
  • Individual metabolism, age, body mass, and kidney/liver function can influence detection times
  • Benzodiazepines can be detected in urine for several days after last use, but the exact timeframe can vary significantly.

From the FDA Drug Label

Using a specific assay methodology, the mean plasma elimination half-life of alprazolam has been found to be about 11.2 hours (range: 6.3–26. 9 hours) in healthy adults. Alprazolam and its metabolites are excreted primarily in the urine

The length of time benzodiazepines test on a urine drug screen (UDS) is not directly stated in the provided drug label. However, considering the half-life of alprazolam, which is approximately 11.2 hours, and that it is extensively metabolized and excreted in the urine, it can be inferred that benzodiazepines like alprazolam may be detectable in urine for a period of time that is several half-lives long.

  • The exact duration of detection is not provided in the label.
  • Key factors that may influence the detection time include individual metabolism, dosage, and frequency of use 2.

From the Research

Benzodiazepines and Urine Drug Screens

  • Benzodiazepines are a class of psychoactive drugs that can be detected in urine drug screens (UDS) 3, 4.
  • However, immunoassays used for initial screening of urine samples may not detect all types of benzodiazepines, such as alprazolam or clonazepam 3.
  • False-positive results can occur due to cross-reactivity with other medications, and false-negative results can cause missed opportunities to detect misuse 3, 4.
  • Commonly prescribed medications, including antihistamines, antidepressants, and antibiotics, can trigger false-positive UDS results for benzodiazepines 4.

Detection Time of Benzodiazepines in UDS

  • The detection time of benzodiazepines in UDS can vary depending on the type of benzodiazepine, the dose, and the individual's metabolism 5.
  • However, there is no specific information available on the exact detection time of benzodiazepines in UDS in the provided studies.
  • It is recommended to use gas chromatography-mass spectrometry to confirm the results of immunoassays and avoid adverse consequences for patients 4.

Clinical Considerations

  • Benzodiazepines have a high potential for addiction and dependence, and their use should be carefully monitored 5.
  • Withdrawal symptoms can be severe and life-threatening, and treatment should be done through tapering with clonazepam or other alternative methods 5.
  • Further research is needed to explore alternative methods of treating benzodiazepine withdrawal and dependence 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urine Drug Tests: Ordering and Interpreting Results.

American family physician, 2019

Research

Commonly prescribed medications and potential false-positive urine drug screens.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.